Search In this Thesis
   Search In this Thesis  
العنوان
Neostigmine Co-administration with Bupivacaine for Caudal Analgesia during Congenital Inguinal Hernia Repair in Pediatrics. /
المؤلف
El-Miseery, Omnia Ali Habeb.
هيئة الاعداد
باحث / امنية على حبيب المسيرى
مشرف / لبنى محمد ابو النصر
مشرف / احمد صبحى بسيونى
مشرف / هشام ابراهيم التطاوى
الموضوع
Anesthesiology. Anesthesia &Surgical ICU.
تاريخ النشر
2016.
عدد الصفحات
p 99. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
العناية المركزة والطب العناية المركزة
تاريخ الإجازة
15/6/2016
مكان الإجازة
جامعة طنطا - كلية الطب - Anesthesia &Surgical ICU
الفهرس
Only 14 pages are availabe for public view

from 133

from 133

Abstract

Post-hernioraphy pain in children is an unpleasant subjective
sensation which can only be experienced by their parents or caregivers
and cannot be expressed.
Caudal epidural analgesia has become one of the most popular
and commonly performed regional blocks in pediatric anesthesia. It can
be used with general anesthesia for intra- and post-operative analgesia.
Prolongation of caudal analgesia has been achieved by the
addition of various additives to bupivacaine including morphine,
tramadol, fentanyl, ketamine, neostigmine, clonidine,
dexmedetomidine, and midazolam. They were used in varying
concentrations in different studies to achieve maximum benefit.
Though neostigmine as an adjuvant to bupivacaine has been reported to
have many advantages, only few studies evaluated the analgesic effect
of caudal neostigmine bupivacaine in children.
The aim of the present study was to evaluate the effect of
neostigmine as an additive for caudal analgesia in congenital inguinal
hernia repair in pediatrics.
The study included 70 pediatric patients, aged from 1 month to
6 years, ASA I-II of both sex presented for open inguinal hernia repair
in Pediatric Surgery Department, Tanta University Hospital, Egypt.
Patients were randomly classified into 2 groups, 35 patients
each to receive either a caudal injection of 0.25% bupivacaine in a total
volume of 1mL/ kg (group I) or a caudal injection of 0.25%.